Best pharmaceutical companies in Raleigh, NC

Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd, a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business. Headquartered in Woodcliff Lake, New Jersey, they are dedicated to a tradition of genuine concern for people and are driven by the desire to help meet the diverse health care needs of patients and their families and caregivers. They are an agile, entrepreneurial organization managed by experienced leadership, backed by the strength, stability and historical successes of Eisai Co., Ltd., which has a strong and lasting commitment to the U.S. market. Their heritage and mission have earned us recognition as an innovative, efficient, solution-oriented pharmaceutical company - a company that effectively works with healthcare professionals, hospitals and managed care organizations to develop and market specialty products that help address unmet needs. Their ability to forge strong alliances gives us a competitive edge. In the United States, their rapid growth and strong performance result from putting patients and their families first when making decisions and from empowering the people who manage their operations. Eisai employees personify their values of integrity, respect, professionalism, quality and teamwork.

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases. The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world. Merck was founded in 1891 and is headquartered in Kenilworth, NJ.

Covance Inc. is a global contract research organization recognized for being the world's most comprehensive drug development company. It has a team of professionals that are dedicated to advancing healthcare and delivering fast and innovative medical solutions to patients and healthcare providers. The company also offers laboratory testing services to the chemical, agrochemical, and food industries. It is also a market leader in central laboratory, toxicology, and discovery services.

Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services

UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with a revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's, and Crohn's diseases.

RedHill Biopharma, established in 2009, is a pharmaceutical company focused primarily on acquisition and development of late clinical-stage new, improved and patented formulations of existing drugs, with preference to a 505(b)(2)* regulatory paths, as well as acquisition and developement of late clinical-stage, new and patented orphan drugs.

We provide TMS therapy, a non-drug, FDA-cleared #Depression & #OCD treatment. Take our quiz to see if #TMStherapy could be right for you: https://t.co/QNvCqWRdQz